PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41.69	56.56	73.82	65.24	28.84
Cash & Short-Term Investments	41.69	56.56	73.82	65.24	28.84
Cash Growth	-26.29%	-23.38%	13.15%	126.23%	137.13%
Prepaid Expenses	3.36	2.49	2.66	1.6	1.5
Total Current Assets	45.05	59.06	76.48	66.84	30.34
Property, Plant & Equipment	0.3	0.34	0.53	0.36	0.55
Total Assets	45.36	59.39	77.01	67.2	30.89
Accounts Payable	1.68	6.98	1.22	1.31	1.42
Accrued Expenses	2.84	2.42	8.31	2.19	1.74
Short-Term Debt	12.5	4.17	-	-	-
Current Portion of Leases	0.06	0.06	0.29	0.26	0.12
Total Current Liabilities	17.09	13.63	9.82	3.76	3.27
Long-Term Debt	9.2	19.51	23.02	-	-
Long-Term Leases	0.06	0.12	0.16	0.23	0.49
Total Liabilities	26.35	33.26	33.01	3.99	3.76
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	201.1	170.62	145.55	123.9	70.91
Retained Earnings	-182.11	-144.5	-101.56	-60.7	-43.79
Shareholders' Equity	19	26.13	44	63.21	27.13
Total Liabilities & Equity	45.36	59.39	77.01	67.2	30.89
Total Debt	21.83	23.85	23.47	0.49	0.61
Net Cash (Debt)	19.86	32.71	50.35	64.75	28.23
Net Cash Growth	-39.28%	-35.03%	-22.25%	129.38%	132.12%
Net Cash Per Share	0.54	1.06	1.76	2.53	1.69
Filing Date Shares Outstanding	45.4	36.68	30.72	28.45	22.26
Total Common Shares Outstanding	37.99	33.09	30.17	28.45	22.26
Working Capital	27.97	45.43	66.66	63.08	27.07
Book Value Per Share	0.50	0.79	1.46	2.22	1.22
Tangible Book Value	19	26.13	44	63.21	27.13
Tangible Book Value Per Share	0.50	0.79	1.46	2.22	1.22
Machinery	0.3	0.27	0.12	0.12	0.12

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q